Information

Related Research Units

Cardiology Research

Publications

  1. Impact of Anticoagulation Therapy after Bioprosthetic and Homograft Pulmonary Valve Replacement. Ann Thorac Surg. 2025 Jan 17. View Abstract
  2. Biventricular Repair of Univentricular Heart Lowers Risk of Liver Disease Compared With the Fontan Operation. JACC Adv. 2025 Jan; 4(1):101429. View Abstract
  3. Wide variation in shape of hypoplastic left ventricles undergoing recruitment and biventricular repair: A statistical shape modeling study. J Cardiovasc Magn Reson. 2024 Dec 06; 27(1):101131. View Abstract
  4. Electrocardiogram-Based Deep Learning to Predict Mortality in Repaired Tetralogy of Fallot. JACC Clin Electrophysiol. 2024 Dec; 10(12):2600-2612. View Abstract
  5. Impact of surgical strategy and postrepair transverse aortic arch size on late hypertension after coarctation repair during infancy. J Thorac Cardiovasc Surg. 2025 Feb; 169(2):345-352. View Abstract
  6. Nutrition Provision in Children with Heart Disease on Extracorporeal Membrane Oxygenation (ECMO). Pediatr Cardiol. 2024 Aug 26. View Abstract
  7. Childhood Opportunity and Acute Interstage Outcomes: A National Pediatric Cardiology Quality Improvement Collaborative Analysis. Circulation. 2024 Jul 16; 150(3):190-202. View Abstract
  8. Development and Validation of a Mortality Risk Score for Repaired Tetralogy of Fallot. J Am Heart Assoc. 2024 Jun 18; 13(12):e034871. View Abstract
  9. Dysregulation of platelet serotonin, 14-3-3, and GPIX in sudden infant death syndrome. Sci Rep. 2024 05 15; 14(1):11092. View Abstract
  10. A prospective multicenter feasibility study of a miniaturized implantable continuous flow ventricular assist device in smaller children with heart failure. J Heart Lung Transplant. 2024 Jun; 43(6):889-900. View Abstract
  11. Risk Factors for Death or Transplant After Stage 2 Palliation for Single Ventricle Heart Disease. JACC Adv. 2024 May; 3(5):100934. View Abstract
  12. Cleft closure and other predictors of contemporary outcomes after atrioventricular canal repair in patients with parachute left atrioventricular valve. Interdiscip Cardiovasc Thorac Surg. 2024 Mar 29; 38(4). View Abstract
  13. Erector spinae plane blocks for opioid-sparing multimodal pain management after pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2024 Dec; 168(6):1742-1750.e9. View Abstract
  14. Multiomic Analysis of Neuroinflammation and Occult Infection in Sudden Infant Death Syndrome. JAMA Neurol. 2024 Mar 01; 81(3):240-247. View Abstract
  15. Mitral valve orifice area predicts outcome after biventricular repair in patients with hypoplastic left ventricles. J Cardiovasc Magn Reson. 2024; 26(1):101029. View Abstract
  16. Technical Success and Serious Adverse Events for Fetal Aortic Valvuloplasty in a Large 20-Year Cohort. JACC Adv. 2024 Mar; 3(3):100835. View Abstract
  17. Stress Ulcer Prophylaxis Versus Placebo-A Blinded Pilot Randomized Controlled Trial to Evaluate the Safety of Two Strategies in Critically Ill Infants With Congenital Heart Disease. Pediatr Crit Care Med. 2024 Feb 01; 25(2):118-127. View Abstract
  18. The experience of fathers of children hospitalised with advanced heart disease. Cardiol Young. 2024 Jun; 34(6):1274-1278. View Abstract
  19. The family burden of paediatric heart disease during the chronic phase of illness. Cardiol Young. 2024 May; 34(5):997-1003. View Abstract
  20. Design and Harmonization Approach for the Multi-Institutional Neurocognitive Discovery Study (MINDS) of Adult Congenital Heart Disease (ACHD) Neuroimaging Ancillary Study: A Technical Note. J Cardiovasc Dev Dis. 2023 Sep 06; 10(9). View Abstract
  21. Impact of Right Ventricular Surface Area-to-Volume Ratio on Ventricular Remodeling After Pulmonary Valve Replacement. Pediatr Cardiol. 2023 Oct; 44(7):1613-1622. View Abstract
  22. Magnetic resonance three-dimensional steady-state free precession imaging of the thoracic duct in patients with Fontan circulation and its relationship to outcomes. J Cardiovasc Magn Reson. 2023 06 12; 25(1):28. View Abstract
  23. Normative Echocardiographic Left Ventricular Parameters and Reference Intervals in Infants. J Am Coll Cardiol. 2023 06 06; 81(22):2175-2185. View Abstract
  24. Improved Outcomes After Pulmonary Valve Replacement in Repaired Tetralogy of Fallot. J Am Coll Cardiol. 2023 05 30; 81(21):2075-2085. View Abstract
  25. Left atrioventricular valve repair after primary atrioventricular canal surgery: Predictors of durability. J Thorac Cardiovasc Surg. 2023 10; 166(4):1168-1177. View Abstract
  26. A comparison between the apical and subcostal view for three-dimensional echocardiographic assessment of right ventricular volumes in pediatric patients. Front Cardiovasc Med. 2023; 10:1137814. View Abstract
  27. Single Ventricle Reconstruction III: Brain Connectome and Neurodevelopmental Outcomes: Design, Recruitment, and Technical Challenges of a Multicenter, Observational Neuroimaging Study. Diagnostics (Basel). 2023 Apr 30; 13(9). View Abstract
  28. Single Ventricle Reconstruction III: Brain Connectome and Neurodevelopmental Outcomes: Design, Recruitment, and Technical Challenges of a Multicenter, Observational Neuroimaging Study. medRxiv. 2023 Apr 17. View Abstract
  29. The teammate trial: Study design and rationale tacrolimus and everolimus against tacrolimus and MMF in pediatric heart transplantation using the major adverse transplant event (MATE) score. Am Heart J. 2023 06; 260:100-112. View Abstract
  30. Factors associated with morbidity, mortality, and hemodynamic failure after biventricular conversion in borderline hypoplastic left hearts. J Thorac Cardiovasc Surg. 2023 09; 166(3):933-942.e3. View Abstract
  31. Pediatric Normal Values and Z Score Equations for Left and Right Ventricular Strain by Two-Dimensional Speckle-Tracking Echocardiography Derived from a Large Cohort of Healthy Children. J Am Soc Echocardiogr. 2023 03; 36(3):310-323. View Abstract
  32. Longitudinal changes in ventricular size and function are associated with death and transplantation late after the Fontan operation. J Cardiovasc Magn Reson. 2022 Nov 14; 24(1):56. View Abstract
  33. Impact of maternal social vulnerability and timing of prenatal care on outcome of prenatally detected congenital heart disease. Ultrasound Obstet Gynecol. 2022 09; 60(3):346-358. View Abstract
  34. Angiotensin receptor blockers and ß blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials. Lancet. 2022 09 10; 400(10355):822-831. View Abstract
  35. Pulmonary Hypertension in Children with Down Syndrome: Results from the Pediatric Pulmonary Hypertension Network Registry. J Pediatr. 2023 01; 252:131-140.e3. View Abstract
  36. Hemodynamic and anatomic changes after fetal aortic valvuloplasty are associated with procedural success and postnatal biventricular circulation. Prenat Diagn. 2022 09; 42(10):1312-1322. View Abstract
  37. Factors determining change in treatment for ambulatory children with pulmonary arterial hypertension: Implications for monitoring. Pulm Circ. 2022 Jul; 12(3):e12121. View Abstract
  38. Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary Hypertension. Ann Am Thorac Soc. 2022 06; 19(6):1000-1012. View Abstract
  39. Cardiovascular intensive care unit variables inform need for feeding tube utilization in infants with hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2023 03; 165(3):1248-1256. View Abstract
  40. Contemporary outcomes of the double switch operation for congenitally corrected transposition of the great arteries. J Thorac Cardiovasc Surg. 2022 12; 164(6):1980-1990.e7. View Abstract
  41. Variability in Longitudinal Early Diastolic Strain Rate in Children: Authors' Reply. J Am Soc Echocardiogr. 2022 07; 35(7):786-788. View Abstract
  42. Associations With Extubation Failure and Predictive Value of Risk Analytics Algorithms With Extubation Readiness Tests Following Congenital Cardiac Surgery. Pediatr Crit Care Med. 2022 04 01; 23(4):e208-e218. View Abstract
  43. A Monte Carlo Simulation Approach to Optimizing Capacity in a High-Volume Congenital Heart Pediatric Surgical Center. Front Health Serv. 2021; 1:787358. View Abstract
  44. Pediatric heart transplant waiting times in the United States since the 2016 allocation policy change. Am J Transplant. 2022 03; 22(3):833-842. View Abstract
  45. Serial cardiac biomarker assessment in adults with congenital heart disease hospitalized for decompensated heart failure?. Int J Cardiol Congenit Heart Dis. 2022 Mar; 7. View Abstract
  46. Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry. Eur Respir J. 2022 01; 59(1). View Abstract
  47. Medullary Serotonergic Binding Deficits and Hippocampal Abnormalities in Sudden Infant Death Syndrome: One or Two Entities? Front Pediatr. 2021; 9:762017. View Abstract
  48. Cardiac MRI predictors of good long-term outcomes in patients with repaired TOF. Am Heart J. 2022 03; 245:70-77. View Abstract
  49. Single-Leaflet Aortic Valve Reconstruction Utilizing the Ozaki Technique in Patients With Congenital Aortic Valve Disease. Semin Thorac Cardiovasc Surg. 2022; 34(4):1262-1272. View Abstract
  50. Enhancing Recovery in Congenital Cardiac Surgery. Ann Thorac Surg. 2022 11; 114(5):1754-1761. View Abstract
  51. Safety of Prolonged Inhalation of Hydrogen Gas in Air in Healthy Adults. Crit Care Explor. 2021 Oct; 3(10):e543. View Abstract
  52. Fluid Restriction Contributes to Poor Nutritional Adequacy in Patients With Congenital Heart Disease Receiving Renal Replacement Therapy. J Ren Nutr. 2022 01; 32(1):78-86. View Abstract
  53. Accuracy of Cardiac Magnetic Resonance Imaging in Diagnosing Pediatric Cardiac Masses: A Multicenter Study. JACC Cardiovasc Imaging. 2022 08; 15(8):1391-1405. View Abstract
  54. Biventricular Global Function Index Is Associated With Adverse Outcomes in Repaired Tetralogy of Fallot. Circ Cardiovasc Imaging. 2021 08; 14(8):e012519. View Abstract
  55. Normal Left Ventricular Systolic and Diastolic Strain Rate Values in Children Derived from Two-Dimensional Speckle-Tracking Echocardiography. J Am Soc Echocardiogr. 2021 12; 34(12):1303-1315.e3. View Abstract
  56. Parent-Reported Symptoms and Perceived Effectiveness of Treatment in Children Hospitalized with Advanced Heart Disease. J Pediatr. 2021 Nov; 238:221-227.e1. View Abstract
  57. Mortality and Reoperation Risk After Bioprosthetic Aortic Valve Replacement in Young Adults With Congenital Heart Disease. Semin Thorac Cardiovasc Surg. 2021; 33(4):1081-1092. View Abstract
  58. Longitudinal changes in extent of late gadolinium enhancement in repaired Tetralogy of Fallot: a retrospective analysis of serial CMRs. J Cardiovasc Magn Reson. 2021 06 21; 23(1):80. View Abstract
  59. Impact of pulmonary valve replacement on left ventricular rotational mechanics in repaired tetralogy of Fallot. J Cardiovasc Magn Reson. 2021 05 24; 23(1):61. View Abstract
  60. Prognostic Significance of Computed Tomography Findings in Pulmonary Vein Stenosis. Children (Basel). 2021 May 17; 8(5). View Abstract
  61. The Association of Age and Repair Modification with Outcome after Cone Repair for Ebstein's Malformation. Semin Thorac Cardiovasc Surg. 2022; 34(1):205-212. View Abstract
  62. Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes Study. J Am Heart Assoc. 2021 05 04; 10(9):e017731. View Abstract
  63. Stratification of Bleeding Risk Using Thromboelastography in Children on Extracorporeal Membrane Oxygenation Support. Pediatr Crit Care Med. 2021 03 01; 22(3):241-250. View Abstract
  64. Life-Threatening Hemoptysis in a Pediatric Referral Center. Crit Care Med. 2021 03 01; 49(3):e291-e303. View Abstract
  65. Late gestation predictors of a postnatal biventricular circulation after fetal aortic valvuloplasty. Prenat Diagn. 2021 03; 41(4):479-485. View Abstract
  66. Risk Factors for Left Ventricular Dysfunction Following Surgical Management of Cardiac Fibroma. Circ Cardiovasc Imaging. 2021 02; 14(2):e011748. View Abstract
  67. Parent and Physician Understanding of Prognosis in Hospitalized Children With Advanced Heart Disease. J Am Heart Assoc. 2021 01 19; 10(2):e018488. View Abstract
  68. Effect of Losartan or Atenolol on Children and Young Adults With Bicuspid Aortic Valve and Dilated Aorta. Am J Cardiol. 2021 04 01; 144:111-117. View Abstract
  69. Prostanoids in pediatric pulmonary hypertension: clinical response, time-to-effect, and dose-response. Pulm Circ. 2020 Oct-Dec; 10(4):2045894020944858. View Abstract
  70. Long-Term Fate of the Truncal Valve. J Am Heart Assoc. 2020 11 17; 9(22):e019104. View Abstract
  71. Bilateral Erector Spinae Blocks Decrease Perioperative Opioid Use After Pediatric Cardiac Surgery. J Cardiothorac Vasc Anesth. 2021 Jul; 35(7):2082-2087. View Abstract
  72. Trajectories in Neurodevelopmental, Health-Related Quality of Life, and Functional Status Outcomes by Socioeconomic Status and Maternal Education in Children with Single Ventricle Heart Disease. J Pediatr. 2021 02; 229:289-293.e3. View Abstract
  73. Socioeconomic Status and Long-term Outcomes in Single Ventricle Heart Disease. Pediatrics. 2020 10; 146(4). View Abstract
  74. Reintervention rates after bioprosthetic pulmonary valve replacement in patients younger than 30 years of age: A multicenter analysis. J Thorac Cardiovasc Surg. 2021 02; 161(2):345-362.e2. View Abstract
  75. Longitudinal Variation in Presence and Severity of Cardiac Valve Regurgitation in Healthy Children. J Am Soc Echocardiogr. 2020 11; 33(11):1400-1406. View Abstract
  76. Changes in Prognosis of Heterotaxy Syndrome Over Time. Pediatrics. 2020 08; 146(2). View Abstract
  77. Variants in ADRB1 and CYP2C9: Association with Response to Atenolol and Losartan in Marfan Syndrome. J Pediatr. 2020 07; 222:213-220.e5. View Abstract
  78. De Novo Damaging Variants, Clinical Phenotypes, and Post-Operative Outcomes in Congenital Heart Disease. Circ Genom Precis Med. 2020 08; 13(4):e002836. View Abstract
  79. Stress ulcer prophylaxis versus placebo-a blinded randomized control trial to evaluate the safety of two strategies in critically ill infants with congenital heart disease (SUPPRESS-CHD). Trials. 2020 Jun 29; 21(1):590. View Abstract
  80. Revisiting prosthesis choice in mitral valve replacement in children: Durable alternatives to traditional bioprostheses. J Thorac Cardiovasc Surg. 2020 May 31. View Abstract
  81. Modified Ozaki Procedure Including Annular Enlargement for Small Aortic Annuli in Young Patients. Ann Thorac Surg. 2020 10; 110(4):1364-1371. View Abstract
  82. Speckle tracking echocardiographically-based analysis of ventricular strain in children: an intervendor comparison. Cardiovasc Ultrasound. 2020 May 21; 18(1):15. View Abstract
  83. Extracorporeal Membrane Oxygenation Support After Heart Transplantation in Children-Outcomes of a Single Center Cohort. Pediatr Crit Care Med. 2020 04; 21(4):332-339. View Abstract
  84. The TEAMMATE Trial: Study Design and Rationale of the First Pediatric Heart Transplant Randomized Clinical Trial. J Heart Lung Transplant. 2020 Apr; 39(4S):S207-S208. View Abstract
  85. The impact of pre-implant illness severity on the outcomes of pediatric patients undergoing durable ventricular assist device. J Heart Lung Transplant. 2020 07; 39(7):666-674. View Abstract
  86. Congenital aortic and truncal valve reconstruction using the Ozaki technique: Short-term clinical results. J Thorac Cardiovasc Surg. 2021 05; 161(5):1567-1577. View Abstract
  87. Value of Troponin Testing for Detection of Heart Disease in Previously Healthy Children. J Am Heart Assoc. 2020 02 18; 9(4):e012897. View Abstract
  88. Relation of Right Ventricular Dilation After Pulmonary Valve Replacement to Outcomes in Patients With Repaired Tetralogy of Fallot. Am J Cardiol. 2020 03 15; 125(6):977-981. View Abstract
  89. Development of a validated risk score for interstage death or transplant after stage I palliation for single-ventricle heart disease. J Thorac Cardiovasc Surg. 2020 Oct; 160(4):1021-1030. View Abstract
  90. Initial experience introducing an enhanced recovery program in congenital cardiac surgery. J Thorac Cardiovasc Surg. 2020 11; 160(5):1313-1321.e5. View Abstract
  91. High-dose heparin is associated with higher bleeding and thrombosis rates in pediatric patients following cardiac surgery. J Thorac Cardiovasc Surg. 2019 10; 158(4):1199-1206. View Abstract
  92. Relation of Fontan Baffle Stroke Volume to Fontan Failure and Lower Exercise Capacity in Patients With an Atriopulmonary Fontan. Am J Cardiol. 2019 07 01; 124(1):151-157. View Abstract
  93. Cardiac Biomarkers in Pediatric Cardiomyopathy: Study Design and Recruitment Results from the Pediatric Cardiomyopathy Registry. Prog Pediatr Cardiol. 2019 Jun; 53:1-10. View Abstract
  94. Normal Values for Left Ventricular Strain and Synchrony in Children Based on Speckle Tracking Echocardiography. Am J Cardiol. 2019 05 01; 123(9):1546-1554. View Abstract
  95. Maldistribution of pulmonary blood flow in patients after the Fontan operation is associated with worse exercise capacity. J Cardiovasc Magn Reson. 2018 12 17; 20(1):85. View Abstract
  96. Three-Dimensional Mitral Valve Morphology in Children and Young Adults With Marfan Syndrome. J Am Soc Echocardiogr. 2018 11; 31(11):1168-1177.e1. View Abstract
  97. Frequency of Ventricular Arrhythmias and Other Rhythm Abnormalities in Children and Young Adults With the Marfan Syndrome. Am J Cardiol. 2018 10 15; 122(8):1429-1436. View Abstract
  98. Echocardiographic predictors of neonatal illness severity in fetuses with critical left heart obstruction with intact or restrictive atrial septum. Prenat Diagn. 2018 09; 38(10):788-794. View Abstract
  99. Improved technical success, postnatal outcome and refined predictors of outcome for fetal aortic valvuloplasty. Ultrasound Obstet Gynecol. 2018 08; 52(2):212-220. View Abstract
  100. Impact of a Composite Valved RV-PA Graft After Stage 1 Palliation. Ann Thorac Surg. 2018 11; 106(5):1452-1459. View Abstract
  101. Systemic Ventricular Dysfunction Between Stage One and Stage Two Palliation. Pediatr Cardiol. 2018 Dec; 39(8):1514-1522. View Abstract
  102. Thromboelastography Is Associated With Surrogates for Bleeding After Pediatric Cardiac Operations. Ann Thorac Surg. 2018 09; 106(3):799-806. View Abstract
  103. Predictors of Postoperative Rehabilitation Therapy Following Congenital Heart Surgery. J Am Heart Assoc. 2018 05 12; 7(10). View Abstract
  104. An anticoagulation protocol for use after congenital cardiac surgery. J Thorac Cardiovasc Surg. 2018 07; 156(1):343-352.e4. View Abstract
  105. Partial thromboplastin time is more predictive of bleeding than anti-Xa levels in heparinized pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg. 2018 07; 156(1):332-340.e1. View Abstract
  106. Long-Term Outcomes of Hypertrophic Cardiomyopathy Diagnosed During Childhood: Results From a National Population-Based Study. Circulation. 2018 07 03; 138(1):29-36. View Abstract
  107. Early hemodynamic changes after fetal aortic stenosis valvuloplasty predict biventricular circulation at birth. Prenat Diagn. 2018 03; 38(4):286-292. View Abstract
  108. Influence of Aortic Stiffness on Aortic-Root Growth Rate and Outcome in Patients With the Marfan Syndrome. Am J Cardiol. 2018 05 01; 121(9):1094-1101. View Abstract
  109. Physician Perspectives on Palliative Care for Children with Advanced Heart Disease: A Comparison between Pediatric Cardiology and Palliative Care Physicians. J Palliat Med. 2018 06; 21(6):773-779. View Abstract
  110. Myocardial injury in fetal aortic stenosis: Insights from amniotic fluid analysis. Prenat Diagn. 2018 02; 38(3):190-195. View Abstract
  111. Neighborhood Socioeconomic Status and Outcomes Following the Norwood Procedure: An Analysis of the Pediatric Heart Network Single Ventricle Reconstruction Trial Public Data Set. J Am Heart Assoc. 2018 02 02; 7(3). View Abstract
  112. Transplant-Free Survival and Interventions at 6 Years in the SVR Trial. Circulation. 2018 05 22; 137(21):2246-2253. View Abstract
  113. Valve-sparing repair with intraoperative balloon dilation in tetralogy of Fallot: Midterm results and therapeutic implications. J Thorac Cardiovasc Surg. 2018 03; 155(3):1163-1173.e4. View Abstract
  114. A propensity score-adjusted analysis of clinical outcomes after pulmonary valve replacement in tetralogy of Fallot. Heart. 2018 05; 104(9):738-744. View Abstract
  115. Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy. Open Heart. 2017; 4(2):e000615. View Abstract
  116. Pediatric Cardiology Provider Attitudes About Palliative Care: A Multicenter Survey Study. Pediatr Cardiol. 2017 Oct; 38(7):1324-1331. View Abstract
  117. The Lateral Temporal Lobe in Early Human Life. J Neuropathol Exp Neurol. 2017 Jun 01; 76(6):424-438. View Abstract
  118. Cerebral near-infrared spectroscopy insensitively detects low cerebral venous oxygen saturations after stage 1 palliation. J Thorac Cardiovasc Surg. 2017 09; 154(3):1056-1062. View Abstract
  119. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study. JAMA Cardiol. 2017 04 01; 2(4):419-428. View Abstract
  120. Differences in Presentation and Outcomes Between Children With Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group. Circ Heart Fail. 2017 Feb; 10(2). View Abstract
  121. Assessment of Diastolic Function in Single-Ventricle Patients After the Fontan Procedure. J Am Soc Echocardiogr. 2016 11; 29(11):1066-1073. View Abstract
  122. Hippocampal Formation Maldevelopment and Sudden Unexpected Death across the Pediatric Age Spectrum. J Neuropathol Exp Neurol. 2016 Oct; 75(10):981-997. View Abstract
  123. Outcome and performance of bioprosthetic pulmonary valve replacement in patients with congenital heart disease. J Thorac Cardiovasc Surg. 2016 11; 152(5):1333-1342.e3. View Abstract
  124. Responsibilities of Data Monitoring Committees: Consensus Recommendations. Ther Innov Regul Sci. 2016 Sep; 50(5):648-659. View Abstract
  125. Heart block following stage 1 palliation of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2016 Jul; 152(1):189-94. View Abstract
  126. Systolic-diastolic functional coupling in healthy children and in those with dilated cardiomyopathy. J Appl Physiol (1985). 2016 Jun 01; 120(11):1301-18. View Abstract
  127. Health-Related Quality of Life and Functional Status Are Associated with Cardiac Status and Clinical Outcome in Children with Cardiomyopathy. J Pediatr. 2016 Mar; 170:173-80.e1-4. View Abstract
  128. Factors affecting Fontan length of stay: Results from the Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg. 2016 Mar; 151(3):669-675.e1. View Abstract
  129. Associations Between Day of Admission and Day of Surgery on Outcome and Resource Utilization in Infants With Hypoplastic Left Heart Syndrome Who Underwent Stage I Palliation (from the Single Ventricle Reconstruction Trial). Am J Cardiol. 2015 Oct 15; 116(8):1263-9. View Abstract
  130. Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. Pediatr Nephrol. 2015 Dec; 30(12):2177-88. View Abstract
  131. Cardiomyopathy Phenotypes and Outcomes for Children With Left Ventricular Myocardial Noncompaction: Results From the Pediatric Cardiomyopathy Registry. J Card Fail. 2015 Nov; 21(11):877-84. View Abstract
  132. The reproducibility and absolute values of echocardiographic measurements of left ventricular size and function in children are algorithm dependent. J Am Soc Echocardiogr. 2015 May; 28(5):549-558.e1. View Abstract
  133. Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration. Am Heart J. 2015 May; 169(5):605-12. View Abstract
  134. Atenolol versus losartan in children and young adults with Marfan's syndrome. N Engl J Med. 2014 Nov 27; 371(22):2061-71. View Abstract
  135. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial. J Am Coll Cardiol. 2014 Sep 23; 64(12):1189-97. View Abstract
  136. Longitudinal assessment of growth in hypoplastic left heart syndrome: results from the single ventricle reconstruction trial. J Am Heart Assoc. 2014 Jun 23; 3(3):e000079. View Abstract
  137. Factors associated with neurodevelopment for children with single ventricle lesions. J Pediatr. 2014 Sep; 165(3):490-496.e8. View Abstract
  138. Technical performance score is associated with outcomes after the Norwood procedure. J Thorac Cardiovasc Surg. 2014 Nov; 148(5):2208-13, 2214.e1-6. View Abstract
  139. Transplantation-free survival and interventions at 3 years in the single ventricle reconstruction trial. Circulation. 2014 May 20; 129(20):2013-20. View Abstract
  140. Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. J Am Coll Cardiol. 2014 Apr 15; 63(14):1405-13. View Abstract
  141. Variability of M-mode versus two-dimensional echocardiography measurements in children with dilated cardiomyopathy. Pediatr Cardiol. 2014 Apr; 35(4):658-67. View Abstract
  142. Predictors of disease progression in pediatric dilated cardiomyopathy. Circ Heart Fail. 2013 Nov; 6(6):1214-22. View Abstract
  143. Risk factors for prolonged length of stay after the stage 2 procedure in the single-ventricle reconstruction trial. J Thorac Cardiovasc Surg. 2014 Jun; 147(6):1791-8, 1798.e1-4. View Abstract
  144. Neuropathologic studies of the encephalopathy of prematurity in the late preterm infant. Clin Perinatol. 2013 Dec; 40(4):707-22. View Abstract
  145. Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry. Lancet. 2013 Dec 07; 382(9908):1889-97. View Abstract
  146. Echocardiographic methods, quality review, and measurement accuracy in a randomized multicenter clinical trial of Marfan syndrome. J Am Soc Echocardiogr. 2013 Jun; 26(6):657-66. View Abstract
  147. The Congenital Heart Disease Genetic Network Study: rationale, design, and early results. Circ Res. 2013 Feb 15; 112(4):698-706. View Abstract
  148. Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial. Circulation. 2013 Feb 19; 127(7):820-31. View Abstract
  149. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012 Dec 20; 367(25):2375-84. View Abstract
  150. The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry. Am Heart J. 2012 Oct; 164(4):591-9. View Abstract
  151. Outcomes in children with Noonan syndrome and hypertrophic cardiomyopathy: a study from the Pediatric Cardiomyopathy Registry. Am Heart J. 2012 Sep; 164(3):442-8. View Abstract
  152. A predictive model for neurodevelopmental outcome after the Norwood procedure. Pediatr Cardiol. 2013 Feb; 34(2):327-33. View Abstract
  153. Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy Registry. Circulation. 2012 Sep 04; 126(10):1237-44. View Abstract
  154. Risk factors for hospital morbidity and mortality after the Norwood procedure: A report from the Pediatric Heart Network Single Ventricle Reconstruction trial. J Thorac Cardiovasc Surg. 2012 Oct; 144(4):882-95. View Abstract
  155. Variation in perioperative care across centers for infants undergoing the Norwood procedure. J Thorac Cardiovasc Surg. 2012 Oct; 144(4):915-21. View Abstract
  156. The ventricular volume variability study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy. J Am Soc Echocardiogr. 2012 Aug; 25(8):842-854.e6. View Abstract
  157. Early developmental outcome in children with hypoplastic left heart syndrome and related anomalies: the single ventricle reconstruction trial. Circulation. 2012 May 01; 125(17):2081-91. View Abstract
  158. Neuron deficit in the white matter and subplate in periventricular leukomalacia. Ann Neurol. 2012 Mar; 71(3):397-406. View Abstract
  159. Intermediate-term mortality and cardiac transplantation in infants with single-ventricle lesions: risk factors and their interaction with shunt type. J Thorac Cardiovasc Surg. 2012 Jul; 144(1):152-9. View Abstract
  160. Incidence of and risk factors for sudden cardiac death in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. J Am Coll Cardiol. 2012 Feb 07; 59(6):607-15. View Abstract
  161. Project VALOR: design and methods of a longitudinal registry of post-traumatic stress disorder (PTSD) in combat-exposed veterans in the Afghanistan and Iraqi military theaters of operations. Int J Methods Psychiatr Res. 2012 Mar; 21(1):5-16. View Abstract
  162. Non-geometric echocardiographic indices of ventricular function in patients with a Fontan circulation. J Am Soc Echocardiogr. 2011 Nov; 24(11):1213-9. View Abstract
  163. Challenges in echocardiographic assessment of mitral regurgitation in children after repair of atrioventricular septal defect. Pediatr Cardiol. 2012 Feb; 33(2):205-14. View Abstract
  164. Surgical interventions for atrioventricular septal defect subtypes: the pediatric heart network experience. Ann Thorac Surg. 2011 Oct; 92(4):1468-75; discussion 1475. View Abstract
  165. Rapid complete reversal of systemic hypoperfusion after intra-aortic balloon pump counterpulsation and survival in cardiogenic shock complicating an acute myocardial infarction. Am Heart J. 2011 Aug; 162(2):268-75. View Abstract
  166. Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. Circulation. 2011 Aug 16; 124(7):814-23. View Abstract
  167. Practice variability and outcomes of coil embolization of aortopulmonary collaterals before Fontan completion: a report from the Pediatric Heart Network Fontan Cross-Sectional Study. Am Heart J. 2011 Jul; 162(1):125-30. View Abstract
  168. Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle. Circulation. 2011 May 31; 123(21):2353-62. View Abstract
  169. Lessons learned from a pediatric clinical trial: the Pediatric Heart Network angiotensin-converting enzyme inhibition in mitral regurgitation study. Am Heart J. 2011 Feb; 161(2):233-40. View Abstract
  170. Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials. Acute Card Care. 2011 Mar; 13(1):14-20. View Abstract
  171. Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J Am Coll Cardiol. 2011 Jan 04; 57(1):86-92. View Abstract
  172. Predictors of coronary artery visualization in Kawasaki disease. J Am Soc Echocardiogr. 2011 Jan; 24(1):53-9. View Abstract
  173. Clinical research careers: reports from a NHLBI pediatric heart network clinical research skills development conference. Am Heart J. 2011 Jan; 161(1):13-67. View Abstract
  174. Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011 May; 158(5):831-835.e3. View Abstract
  175. Surgical management of complete atrioventricular septal defect: associations with surgical technique, age, and trisomy 21. J Thorac Cardiovasc Surg. 2011 Jun; 141(6):1371-9. View Abstract
  176. The Fontan patient: inconsistencies in medication therapy across seven pediatric heart network centers. Pediatr Cardiol. 2010 Nov; 31(8):1219-28. View Abstract
  177. The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin. 2010 Oct; 6(4):401-13, vii. View Abstract
  178. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry. Circ Heart Fail. 2010 Nov; 3(6):689-97. View Abstract
  179. Arrhythmias in a contemporary fontan cohort: prevalence and clinical associations in a multicenter cross-sectional study. J Am Coll Cardiol. 2010 Sep 07; 56(11):890-6. View Abstract
  180. A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry. Am Heart J. 2010 Sep; 160(3):443-50. View Abstract
  181. Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation. 2010 Jul 27; 122(4):333-40. View Abstract
  182. Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med. 2010 May 27; 362(21):1980-92. View Abstract
  183. Partial and transitional atrioventricular septal defect outcomes. Ann Thorac Surg. 2010 Feb; 89(2):530-6. View Abstract
  184. Laboratory measures of exercise capacity and ventricular characteristics and function are weakly associated with functional health status after Fontan procedure. Circulation. 2010 Jan 05; 121(1):34-42. View Abstract
  185. Association of left ventricular dilation at listing for heart transplant with postlisting and early posttransplant mortality in children with dilated cardiomyopathy. Circ Heart Fail. 2009 Nov; 2(6):591-8. View Abstract
  186. Functional state following the Fontan procedure. Cardiol Young. 2009 Aug; 19(4):320-30. View Abstract
  187. Treating children with idiopathic dilated cardiomyopathy (from the Pediatric Cardiomyopathy Registry). Am J Cardiol. 2009 Jul 15; 104(2):281-6. View Abstract
  188. Cardiogenic shock without flow-limiting angiographic coronary artery disease: (from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry). Am J Cardiol. 2009 Jul 01; 104(1):24-8. View Abstract
  189. Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle. Am Heart J. 2009 Jan; 157(1):37-45. View Abstract
  190. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol. 2008 Jul 08; 52(2):85-98. View Abstract
  191. Functional status, heart rate, and rhythm abnormalities in 521 Fontan patients 6 to 18 years of age. J Thorac Cardiovasc Surg. 2008 Jul; 136(1):100-7, 107.e1. View Abstract
  192. Design and rationale of a randomized trial comparing the Blalock-Taussig and right ventricle-pulmonary artery shunts in the Norwood procedure. J Thorac Cardiovasc Surg. 2008 Oct; 136(4):968-75. View Abstract
  193. The Pediatric Cardiomyopathy Registry: 1995-2007. Prog Pediatr Cardiol. 2008 Apr; 25(1):31-36. View Abstract
  194. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am Heart J. 2008 Jun; 155(6):998-1005. View Abstract
  195. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Am Heart J. 2008 Feb; 155(2):215-23. View Abstract
  196. Impact of the New York State Cardiac Surgery and Percutaneous Coronary Intervention Reporting System on the management of patients with acute myocardial infarction complicated by cardiogenic shock. Am Heart J. 2008 Feb; 155(2):267-73. View Abstract
  197. Heart rate and blood pressure response in adult men and women during exercise and sexual activity. Am J Cardiol. 2007 Dec 15; 100(12):1795-801. View Abstract
  198. Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics. 2007 Dec; 120(6):e1434-40. View Abstract
  199. Functional state of patients with heterotaxy syndrome following the Fontan operation. Cardiol Young. 2007 Sep; 17 Suppl 2:44-53. View Abstract
  200. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007 Feb 15; 356(7):663-75. View Abstract
  201. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation. 2007 Feb 13; 115(6):773-81. View Abstract
  202. Microbiological profile of septic complication in patients with cardiogenic shock following acute myocardial infarction (from the SHOCK study). Am J Cardiol. 2007 Mar 15; 99(6):802-4. View Abstract
  203. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006 Oct 18; 296(15):1867-76. View Abstract
  204. Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics. 2006 Oct; 118(4):1519-31. View Abstract
  205. Design of a large cross-sectional study to facilitate future clinical trials in children with the Fontan palliation. Am Heart J. 2006 Sep; 152(3):427-33. View Abstract
  206. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006 Jun 07; 295(21):2511-5. View Abstract
  207. An early revascularization strategy is associated with a survival benefit for diabetic patients in cardiogenic shock after acute myocardial infarction. Clin Cardiol. 2006 May; 29(5):204-10. View Abstract
  208. The Pediatric Heart Network: a primer for the conduct of multicenter studies in children with congenital and acquired heart disease. Pediatr Cardiol. 2006 Mar-Apr; 27(2):191-8. View Abstract
  209. Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry. Eur Heart J. 2006 Mar; 27(6):664-70. View Abstract
  210. Hypoxic-ischemic brain injury in infants with congenital heart disease dying after cardiac surgery. Acta Neuropathol. 2005 Dec; 110(6):563-78. View Abstract
  211. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation. 2005 Sep 27; 112(13):1992-2001. View Abstract
  212. Quantitative analysis of the corpus callosum in children with cerebral palsy and developmental delay: correlation with cerebral white matter volume. Pediatr Radiol. 2005 Dec; 35(12):1199-207. View Abstract
  213. Racial and ethnic differences in the treatment and outcome of cardiogenic shock following acute myocardial infarction. Am J Cardiol. 2005 Oct 15; 96(8):1042-9. View Abstract
  214. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. 2005 Jul 25; 165(14):1643-50. View Abstract
  215. Comparative anatomical assessment of the piglet as a model for the developing human medullary serotonergic system. Brain Res Brain Res Rev. 2005 Dec 01; 50(1):169-83. View Abstract
  216. Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol. 2005 Jul 19; 46(2):266-73. View Abstract
  217. Cardiogenic shock: predictors of outcome based on right and left ventricular size and function at presentation. Coron Artery Dis. 2005 Jun; 16(4):209-15. View Abstract
  218. Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization? Am Heart J. 2005 Jun; 149(6):1128-34. View Abstract
  219. Electrocardiographic findings in cardiogenic shock, risk prediction, and the effects of emergency revascularization: results from the SHOCK trial. Am Heart J. 2004 Nov; 148(5):810-7. View Abstract
  220. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol. 2004 Apr 21; 43(8):1432-8. View Abstract
  221. Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial. Am Heart J. 2003 Nov; 146(5):804-10. View Abstract
  222. Serotonergic brainstem abnormalities in Northern Plains Indians with the sudden infant death syndrome. J Neuropathol Exp Neurol. 2003 Nov; 62(11):1178-91. View Abstract
  223. Correlates of one-year survival inpatients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial. J Am Coll Cardiol. 2003 Oct 15; 42(8):1373-9. View Abstract
  224. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol. 2003 Oct 15; 42(8):1380-6. View Abstract
  225. Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J. 2003 May; 24(9):828-37. View Abstract
  226. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003 Apr 24; 348(17):1647-55. View Abstract
  227. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. J Am Coll Cardiol. 2003 Apr 16; 41(8):1273-9. View Abstract
  228. Primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Lancet. 2003 Apr 12; 361(9365):1303-4; author reply 1304-5. View Abstract
  229. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock. Circulation. 2003 Jan 21; 107(2):279-84. View Abstract
  230. Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. A report from the SHOCK Trial Registry. J Am Coll Cardiol. 2001 Nov 01; 38(5):1395-401. View Abstract
  231. Volumetric brain differences in children with periventricular T2-signal hyperintensities: a grouping by gestational age at birth. AJR Am J Roentgenol. 2001 Sep; 177(3):695-702. View Abstract
  232. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001 Sep; 139(3):385-90. View Abstract
  233. Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. Am Heart J. 2001 Jun; 141(6):964-70. View Abstract
  234. Trends in cardiogenic shock: report from the SHOCK Study. The SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? Eur Heart J. 2001 Mar; 22(6):472-8. View Abstract
  235. Alpha2 receptor binding in the medulla oblongata in the sudden infant death syndrome. J Neuropathol Exp Neurol. 2001 Feb; 60(2):141-6. View Abstract
  236. One-year survival following early revascularization for cardiogenic shock. JAMA. 2001 Jan 10; 285(2):190-2. View Abstract
  237. Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000 Sep; 36(3 Suppl A):1063-70. View Abstract
  238. The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol. 2000 Sep; 36(3 Suppl A):1071-6. View Abstract
  239. Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000 Sep; 36(3 Suppl A):1077-83. View Abstract
  240. Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000 Sep; 36(3 Suppl A):1084-90. View Abstract
  241. Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded coronaries for Cardiogenic shocK? J Am Coll Cardiol. 2000 Sep; 36(3 Suppl A):1091-6. View Abstract
  242. Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000 Sep; 36(3 Suppl A):1097-103. View Abstract
  243. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol. 2000 Sep; 36(3 Suppl A):1104-9. View Abstract
  244. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J Am Coll Cardiol. 2000 Sep; 36(3 Suppl A):1110-6. View Abstract
  245. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000 Sep; 36(3 Suppl A):1123-9. View Abstract
  246. Decreased serotonergic receptor binding in rhombic lip-derived regions of the medulla oblongata in the sudden infant death syndrome. J Neuropathol Exp Neurol. 2000 May; 59(5):377-84. View Abstract
  247. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. Am J Med. 2000 Apr 01; 108(5):374-80. View Abstract
  248. Registration of three-dimensional MR and CT studies of the cervical spine. AJNR Am J Neuroradiol. 2000 Feb; 21(2):282-9. View Abstract
  249. Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J. 2000 Feb; 139(2 Pt 3):S86-95. View Abstract
  250. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000 Jan 13; 342(2):83-9. View Abstract
  251. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999 Aug 26; 341(9):625-34. View Abstract
  252. Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. The Cooperative Study of Sickle Cell Disease. Pediatrics. 1999 Mar; 103(3):640-5. View Abstract
  253. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK: an international randomized trial of emergency PTCA/CABG-trial design. The SHOCK Trial Study Group. Am Heart J. 1999 Feb; 137(2):313-21. View Abstract
  254. Brainstem 3H-nicotine receptor binding in the sudden infant death syndrome. J Neuropathol Exp Neurol. 1998 Nov; 57(11):1018-25. View Abstract
  255. Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death. Clin Infect Dis. 1998 Jun; 26(6):1302-9. View Abstract
  256. Developmental changes in heterogeneous patterns of neurotransmitter receptor binding in the human interpeduncular nucleus. J Comp Neurol. 1998 Jan 19; 390(3):322-32. View Abstract
  257. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998 Jan 01; 91(1):288-94. View Abstract
  258. Decreased kainate receptor binding in the arcuate nucleus of the sudden infant death syndrome. J Neuropathol Exp Neurol. 1997 Nov; 56(11):1253-61. View Abstract
  259. Growth hormone secretion in HIV-positive versus HIV-negative hemophilic males with abnormal growth and pubertal development. The Hemophilia Growth and Development Study. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jun 01; 15(2):137-44. View Abstract
  260. Observer variability in the diagnosis and management of the hysterosalpingogram. Fertil Steril. 1997 Feb; 67(2):233-7. View Abstract
  261. A home-based exercise program for nondisabled older adults. J Am Geriatr Soc. 1996 Jun; 44(6):644-9. View Abstract
  262. Evidence for a shift from a type I lymphocyte pattern with HIV disease progression. Hemophilia Growth and Development Study. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 01; 10(4):471-6. View Abstract
  263. Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases. Blood. 1995 Nov 15; 86(10):3676-84. View Abstract
  264. Decreased muscarinic receptor binding in the arcuate nucleus in sudden infant death syndrome. Science. 1995 Sep 08; 269(5229):1446-50. View Abstract
  265. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood. 1995 Jul 15; 86(2):776-83. View Abstract
  266. Estimation methods for the join distribution of repeated binary observations. Biometrics. 1995 Jun; 51(2):562-70. View Abstract
  267. The reproducibility of the postcoital test: a prospective study. Obstet Gynecol. 1995 Mar; 85(3):396-400. View Abstract
  268. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation. 1995 Feb 01; 91(3):873-81. View Abstract
  269. Evaluation of an implantable ventricular assist system for humans with chronic refractory heart failure. Designing a randomized trial. ASAIO J. 1995 Jan-Mar; 41(1):16-22. View Abstract
  270. The influence of infant and maternal sickle cell disease on birth outcome and neonatal course. Arch Pediatr Adolesc Med. 1994 Nov; 148(11):1156-62. View Abstract
  271. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease. Arch Pediatr Adolesc Med. 1994 Aug; 148(8):796-804. View Abstract
  272. Delayed somatic growth and pubertal development in human immunodeficiency virus-infected hemophiliac boys: Hemophilia Growth and Development Study. J Pediatr. 1994 Jun; 124(6):896-902. View Abstract
  273. Immune and serologic profiles of HIV-infected and noninfected hemophilic children and adolescents. Hemophilia Growth and Development Study Group. Am J Hematol. 1994 May; 46(1):29-35. View Abstract
  274. Behavior, family function, school performance, and predictors of persistent disturbance in sexually abused children. Pediatrics. 1994 Mar; 93(3):452-9. View Abstract
  275. Osteonecrosis of the humeral head in sickle cell disease. Clin Orthop Relat Res. 1993 Apr; (289):136-43. View Abstract
  276. High-risk profiles for nursing home admission. Gerontologist. 1992 Oct; 32(5):634-40. View Abstract
  277. Flexible covariate effects in the proportional hazards model. Breast Cancer Res Treat. 1992; 22(3):241-50. View Abstract
  278. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med. 1991 Nov 21; 325(21):1476-81. View Abstract
  279. Six-year results of the Eastern Cooperative Oncology Group trial of observation versus CMFP versus CMFPT in postmenopausal patients with node-positive breast cancer. J Clin Oncol. 1989 Jul; 7(7):879-89. View Abstract
  280. Risk factors for intraoperative complications in 1000 extracapsular cataract cases. Ophthalmology. 1987 May; 94(5):461-6. View Abstract
  281. Effect of wearing chemical protective clothing in the heat on signal detection over the visual field. Aviat Space Environ Med. 1986 Feb; 57(2):144-8. View Abstract

Contact Lynn A. Sleeper

Print Profile